The project of experimental testing of the hypothesis regarding the effect of sodium phenylbutyrate for reducing dopamine depletion in the brain in Lesch-Nyhan syndrome using new personalized genetic HPRT1-deficient mouse as a pharmacological model
inborn error of purine metabolism which is caused by mutations in the HPRT1 gene encoding the purine recycling enzyme hypoxanthine-guanine phosphoribosyltransferase (HPTR), the prevalence is approximately

